Assessment of interleukin-1 gene cluster polymorphisms in lone atrial fibrillation: New insight into the role of inflammation in atrial fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 36, Issue 10, 2013, Pages 1220-1227

  Gungor, Baris ^a   Ekmekci, Ahmet ^a   Arman, Ahmet ^b   Ozcan, Kazim S ^a   Ucer, Ekrem ^c   Alper, Ahmet T ^a   Calik, Nazmi ^a   Yilmaz, Hale ^a   Tezel, Tuna ^a   Coker, Ajda ^d   Bolca, Osman ^a  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d ISTANBUL KULTUR UNIVERSITY   (Turkey)

Author keywords

CRP; interleukin polymorphism; lone atrial fibrillation

Indexed keywords

C REACTIVE PROTEIN; GENOMIC DNA; INTERLEUKIN 1;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENOTYPE; HEART ATRIUM FIBRILLATION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

CRP; INTERLEUKIN POLYMORPHISM; LONE ATRIAL FIBRILLATION;

ADULT; ATRIAL FIBRILLATION; BASE SEQUENCE; COMORBIDITY; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; MALE; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS; TURKEY;

EID: 84886421454     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12182     Document Type: Article

References (59)

1. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455-2461.
2. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR Jr, Ilstrup DM, Frye RL,. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 1987; 317: 669-674.
3. Frustaci A, Caldarulo M, Buffon A, Bellocci F, Fenici R, Melina D,. Cardiac biopsy in patients with "primary" atrial fibrillation. Histologic evidence of occult myocardial diseases. Chest 1991; 100: 303-306.
4. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-2891.
5. Roldán V, Marín F, Blann AD, García A, Marco P, Sogorb F, Lip GY, et al. Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J 2003; 24: 1373-1380.
6. Psychari SN, Apostolou TS, Sinos L, Hamodraka E, Liakos G, Kremastino DT,. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 2005; 95: 764-767.
7. Conway DS, Buggins P, Hughes E, Lip GY,. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J 2004; 148: 462-466.
8. Liu T, Li G, Li L, Korantzopoulos P,. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: A meta-analysis. J Am Coll Cardiol 2007; 49: 1642-1648.
9. Steinkasserer A, Spurr NK, Cox S, Jeggo P, Sim RB,. The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci. Genomics 1992; 13: 654-657.
10. Nicklin MJH, Weith A, Duff GW,. A physical map of the region encompassing the human interleukin-1, interleukin-1b, and interleukin-1 receptor antagonist genes. Genomics 1994; 19: 382-384.
11. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW,. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Human Genet 1993; 91: 403-404.
12. diGiovine FS, Takhsh E, Blakemore AI, Duff GW,. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1992; 1: 450.
13. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J,. A Taq I polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992; 22: 396-402.
14. Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND, Jeffery S, et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 1999; 99: 861-866.
15. Worrall BB, Azhar S, Nyquist PA, Ackerman RH, Hamm TL, DeGraba TJ,. Interleukin-1 receptor antagonist gene polymorphisms in carotid atherosclerosis. Stroke 2003; 34: 790-793.
16. Blakemore AI, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW,. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1380-1385.
17. Kerkhof HJ, Doherty M, Arden NK, Abramson SB, Attur M, Bos SD, Cooper C, et al. Large-scale meta-analysis of interleukin-1 beta and interleukin-1 receptor antagonist polymorphisms on risk of radiographic hip and knee osteoarthritis and severity of knee osteoarthritis. Osteoarthritis Cartilage 2011; 19: 265-271.
18. Schnabel RB, Kerr KF, Lubitz SA, Alkylbekova EL, Marcus GM, Sinner MF, Magnani JW, et al. Candidate Gene Association Resource (CARe) Atrial Fibrillation/Electrocardiography Working Group. Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: The National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project. Circ Cardiovasc Genet 2011; 4: 557-564.
19. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, et al. Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace 2010; 12: 1360-1420.
20. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
21. Rifai N, Ridker PM,. High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease. Clin Chem 2001; 47: 403-411.
22. Arman A, Yilmaz B, Coker A, Inanc N, Direskeneli H,. Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis. Clin Exp Rheumatol 2006; 24: 643-648.
23. Nattel S,. From guidelines to bench: Implications of unresolved clinical issues for basic investigation of atrial fibrillation mechanisms. Can J Cardiol 2011; 27: 19-26.
24. MMalouf JF, Kanagala R, Al Atawi FO, Rosales AG, Davison DE, Murali NS, Tsang TS, et al. High sensitivity C-reactive protein: A novel predictor for recurrence of atrial fibrillation after successful cardioversion. J Am Coll Cardiol 2005; 46: 1284-1287.
25. Li J, Solus J, Chen Q, Rho YH, Milne G, Stein CM, Darbar D,. Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm 2010; 7: 438-444.
26. Ellinor PT, Low A, Patton KK, Shea MA, MacRae CA,. C-Reactive protein in lone atrial fibrillation. Am J Cardiol 2006; 98: 991-992.
27. Schnabel RB, Larson MG, Yamamoto JF, Kathiresan S, Rong J, Levy D, Keaney JF Jr., et al. Relation of multiple inflammatory biomarkers to incident atrial fibrillation. Am J Cardiol 2009; 104: 92-96.
28. Wolff L,. Familial auricular fibrillation. N Engl J Med 1943; 229: 396-397.
29. Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, Jin HW, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003; 299: 251-254.
30. Yang Y, Xia M, Jin Q, Bendahhou S, Shi J, Chen Y, Liang B, et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004; 75: 899-905.
31. Darbar D, Kannankeril PJ, Donahue BS, Kucera G, Stubblefield T, Haines JL, George AL Jr, et al. Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation 2008; 117: 1927-1935.
32. Hodgson-Zingman DM, Karst ML, Zingman LV, Heublein DM, Darbar D, Herron KJ, Ballew JD, et al. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med 2008; 359: 158-165.
33. Gollob MH, Jones DL, Krahn AD, Danis L, Gong XQ, Shao Q, Liu X, et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 2006; 354: 2677-2688.
34. Xiao P, Ling Z, Woo K, Du H, Su L, Liu Z, Yin Y,. Renin-angiotensin system-related gene polymorphisms are associated with risk of atrial fibrillation. Am Heart J 2010; 160: 496-505.
35. Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A, Jonasdottir A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007; 448: 353-357.
36. Benjamin EJ, Rice KM, Arking DE, Pfeufer A, van Noord C, Smith AV, Schnabel RB, et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet 2009; 41: 879-281.
37. Gudbjartsson DF, Holm H, Gretarsdottir S, Thorleifsson G, Walters GB, Thorgeirsson G, Gulcher J, et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet 2009; 41: 876-878.
38. Ellinor PT, Lunetta KL, Glazer NL, Pfeufer A, Alonso A, Chung MK, Sinner MF, et al. Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet 2010; 42: 240-244.
39. Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, Arking DE, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 2012; 44: 670-675.
40. Yamamoto-Furusho JK, Santiago-Hernández JJ, Pérez- Hernández N, Ramírez-Fuentes S, Fragoso JM, Vargas-Alarcõn G,. Interleukin 1 β (IL-1B) and IL-1 antagonist receptor (IL-1RN) gene polymorphisms are associated with the genetic susceptibility and steroid dependence in patients with ulcerative colitis. J Clin Gastroenterol 2011; 45: 531-535.
41. Nikolopoulos GK, Dimou NL, Hamodrakas SJ, Bagos PG,. Cytokine gene polymorphisms in periodontal disease: A meta-analysis of 53 studies including 4178 cases and 4590 controls. J Clin Periodontol 2008; 35: 754-767.
42. Zhang, Y., Liu C, Peng H, Zhang J, Feng Q,. IL1 receptor antagonist gene IL1-RN variable number of tandem repeats polymorphism and cancer risk: A literature review and meta-analysis. PLoS ONE 2012; 7: e46017.
43. Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, Lorenzet R, Del Zotto E, et al. Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 2005; 25: 222-227.
44. Miranda-Malpica E, Martínez-Rios MA, Fragoso JM, Delgadillo-Rodríguez H, Rodríguez-Pérez JM, González-Quesada C, Martínez-Rodríguez N, et al. The interleukin 1B-511 polymorphism is associated with the risk of developing restenosis after coronary stenting in Mexican patients. Hum Immunol 2008; 69: 116-121.
45. Gaudino M, Andreotti F, Zamparelli R, Di Castelnuovo A, Nasso G, Burzotta F, Iacoviello L, et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication. Circulation 2003; 108 (Suppl 1): II195-199.
46. Li J, Song J, Jiang MH, Zheng JG, Gao SP, Zhu JH, Pan M,. Interleukin-6 promoter polymorphisms and susceptibility to atrial fibrillation in elderly hanchinese patients with essential hypertension. J Interferon Cytokine Res 2012; 32: 542-547.
47. Marcus GM, Whooley MA, Glidden DV, Pawlikowska L, Zaroff JG, Olgin JE, et al. Interleukin-6 and atrial fibrillation in patients with coronary artery disease: Data from the Heart and Soul Study. Am Heart J 2008; 155: 303-309.
48. Rafiq S, Frayling TM, Murray A, Hurst A, Stevens K, Weedon MN, Henley W,. A common variant of theinterleukin6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other inflammatory effects. Genes Immun 2007; 8: 552-559.
49. Reich D, Patterson N, Ramesh V, De Jager PL, McDonald GJ, Tandon A, Choy E, et al. Admixture mapping of an allele affecting interleukin 6 soluble receptor. Am J Hum Genet 2007; 80: 716-726.
50. Francis SE, Camp NJ, Burton AJ, Dewberry RM, Gunn J, Stephens-Lloyd A, Cumberland DC, et al. Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty. Heart 2001; 86: 336-340.
51. Kastrati A, Koch W, Berger PB, Mehilli J, Stephenson K, Neumann FJ, von Beckerath N, et al. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol 2000; 36: 2168-2173.
52. Santtila S, Savinainen K, Hurme M,. Presence of the IL-1RA allele 2 (IL1RN 2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 1998; 47: 195-198.
53. Strandberg L, Lorentzon M, Hellqvist A, Nilsson S, Wallenius V, Ohlsson C, Jansson JO,. Interleukin-1 system gene polymorphisms are associated with fat mass in young men. J Clin Endocrinol Metab 2006; 91: 2749-2754.
54. Furst DE,. Anakinra: Review of recombinant human interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis. Clin Ther 2004; 26: 1960-1975.
55. Dinarello CA,. The role of interleukin-1 receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med 2000; 343: 732-734.
56. Ikonomidis I, Lekakis JP, Nikolaou M, Paraskevaidis I, Andreadou I, Kaplanoglou T, Katsimbri P, et al. Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation 2008; 117: 2662-2669.
57. Abbate A, Salloum FN, Vecile E, Das A, Hoke NN, Straino S, Biondi-Zoccai GG, et al. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation 2008; 117: 2670-2683.
58. Abbate A, Kontos MC, Grizzard JD, Biondi-Zoccai GG, Van Tassell BW, Robati R, Roach LM, et al. VCU-ART Investigators. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). Am J Cardiol 2010; 105: 1371-1377.
59. Vassilopoulos D, Lazaros G, Tsioufis C, Vasileiou P, Stefanadis C, Pectasides D,. Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra). Int J Cardiol 2012; 160: 66-68.